Nested Knowledge presents poster at the 2020 International Stroke Conference

Nested Knowledge presents poster at the 2020 International Stroke Conference
Parvathy Hariharan

Nested Knowledge presents poster at the 2020 International Stroke Conference

PAUL, MN: February 19, 2020 – Nested Knowledge, a medical data analytics company that visualizes research data from primary studies in a dynamic and interactive format, presented its second research poster at the 2020 International Stroke Conference on February 19, 2020, at Atlanta, GA.

The focus of the poster is the largest ever systematic review and meta-analysis on the usage of balloon guide catheters (BGCs) on outcomes for acute ischemic stroke. Researchers used specific search terms in the PubMed database through the Nested Knowledge search/gathering interface to analyze the impact of using BGCs during thrombectomy treatments for stroke. In comparison with non-BGC based treatments, BGCs had a higher rate of successful recanalization with blood flow being restored to more than half of the previously blocked blood vessel (TICI 2b/3). These results also held true for using BGCs in combination with stent retrievers or with combinations of aspiration and stent retrievers. The rates of good neurological outcome (mRS 0-2) were also higher for BGCs, both alone and in combination with stent retrievers, in comparison with non-BGC based methods. Interestingly, contact aspiration had the highest chances for survival at 90 days, regardless of BGC use. The research was presented in association with Superior Medical Experts, a contract research company based in St. Paul.

About Nested Knowledge:

Nested Knowledge is a medical publishing and analytics company whose primary activity is providing and iteratively improving a platform that presents scientific research from thousands of primary clinical studies in a dynamic, updatable, interactive visual interface. Our software uses specialized algorithms to complete searches, facilitate data gathering from studies, quality-control inputs, and organize data into structured and updateable visuals in partnership with leading research organizations. Our vision is to gather all clinical outcomes data in a single, central system of record and enable treatment, regulatory, insurance, investment, and R&D decisions to be driven by comprehensive, evidence-based analysis in this centralized platform.

 

Contact

Keith Kallmes

President, Nested Knowledge

1-507-271-7051

keith.kallmes@nested-knowledge.com

 

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, the Company’s plans, strategies and prospects for its business. All statements, other than statements of historical facts, contained in this press release, including statements regarding the Company’s strategy, future operations, future financial position, prospects, plans and objectives of management, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Any forward-looking statements are based on management’s current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in, or implied by, such forward-looking statements. These risks and uncertainties include, but are not limited to, risks associated with the Company’s ability to: achieve development objectives; meet internal or external quality control goals; continue to provide its current platform or any existing capabilities; advance any development, research, or business objective under the timelines currently anticipated, or at all; obtain, maintain, or protect intellectual property rights related to its products; manage expenses; and raise the substantial additional capital needed to achieve its business objectives. In addition, the forward-looking statements included in this press release represent the Company’s views as of the date hereof and should not be relied upon as representing the Company’s views as of any date subsequent to the date hereof. The Company anticipates that subsequent events and developments will cause the Company’s views to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so.